Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection.
Fuchen LiuXiaochen FengJin DuMinghao RuanHui LiuPublished in: Cancer communications (London, England) (2022)